Trident Lifeline Ltd.
Snapshot View

130.00 -4.45 ▼-3.3%

25 November 2022, 04:01:00 PM
Volume: 6,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.tridentlifeline.com
Market Cap 149.49 Cr.
Enterprise Value(EV) 151.81 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.96 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 66.47 Trailing Twelve Months Ending 2022-03
Industry PE 35.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 34.89 Trailing Twelve Months Ending 2022-03
Price to Book Value 3.73 Calculated using Price: 130.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.15 Cr. 11,499,200 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.31%
1 Week
+2.28%
1 Month
-10.00%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year
1 years 2022-03
Return on Equity (%) 47.75
Return on Capital Employed (%) 44.06
Return on Assets (%) 17.88

Balance Sheet View Details >>

Particulars 1 years 2022-03 Rs. Cr.
Shh. Funds 5
Non Curr. Liab. 0
Curr. Liab. 8
Minority Int.
Equity & Liab. 13
Non Curr. Assets 2
Curr. Assets 11
Misc. Exp. not W/O
Total Assets 13

Profit Loss View Details >>

Particulars 1 years 2022-03 Rs. Cr.
Net Sales 22
Other Income 1
Total Income 22
Total Expenditure -19
PBIDT 3
Interest 0
Depreciation 0
Taxation -1
Exceptional Items
PAT 2
Minority Interest
Share Associate 0
Other Related Items
Consolidated Net Profit 2
Adjusted EPS 3

Cash Flow View Details >>

Particulars 1 years 2022-03 Rs. Cr.
Cash Fr. Operatn. 0
Cash Fr. Inv. 0
Cash Fr. Finan. 1
Net Change 0
Cash & Cash Eqvt 0

Shareholding Pattern View Details >>

No shareholding pattern found.

Announcements View Details >>

Sat, 26 Nov 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
Fri, 25 Nov 2022
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
Please find enclosed herewith disclosure received from Mr. Hardik Jigishkumar Desai Trustee of Hardik Desai Family Trust in terms of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011.
Thu, 24 Nov 2022
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
Please find enclosed herewith disclosure received from Mr. Hardik Jigishkumar Desai Trustee of Hardik Desai Family Trust in terms of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011.

Technical Scans View Details >>

Fri, 25 Nov 2022
Opening at Low Opening at Low
High Decrease 1 Month High Decrease 1 Month
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Above Close Crossing 20 SMA From Above
Close Crossing 20 EMA From Above Close Crossing 20 EMA From Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Trident Lifeline Ltd.

What is Trident Lifeline share price?

Can I buy Trident Lifeline shares now?

What is the Market Cap of Trident Lifeline?

What are the key metrics to analyse Trident Lifeline?

What is the 52 Week High and Low of Trident Lifeline?

What is the trend of Trident Lifeline share price?